Clinical Trial

Phase I Study of CPD704 Inhalation Suspension in Healthy Subjects

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated December 24, 2025 (before its estimated June 8, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a Phase I clinical trial evaluating the safety, tolerability, and pharmacokinetic characteristics of single and multiple doses of CPD704 inhalation suspension in healthy Chinese adult subjects.
Trial Details
NCT Number NCT07301203
Lead Sponsor Beijing Tide Pharmaceutical Co., Ltd
Conditions Healthy, Healthy Participants
Enrollment 90 participants
Start Date 2025-10-21
Primary Completion 2026-06-08 (estimated)
Study Completion 2026-07-18 (estimated)
Updated on ClinicalTrials.gov 2025-12-24